rs2393607

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020987.5(ANK3):​c.13066-44C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.758 in 1,604,790 control chromosomes in the GnomAD database, including 461,187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 40096 hom., cov: 32)
Exomes 𝑓: 0.76 ( 421091 hom. )

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.699

Publications

5 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 10-60042803-G-T is Benign according to our data. Variant chr10-60042803-G-T is described in ClinVar as Benign. ClinVar VariationId is 1192428.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.818 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020987.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
NM_020987.5
MANE Select
c.13066-44C>A
intron
N/ANP_066267.2
ANK3
NM_001204404.2
c.5539-44C>A
intron
N/ANP_001191333.1Q12955-4
ANK3
NM_001320874.2
c.5536-44C>A
intron
N/ANP_001307803.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
ENST00000280772.7
TSL:1 MANE Select
c.13066-44C>A
intron
N/AENSP00000280772.1Q12955-3
ANK3
ENST00000373827.6
TSL:1
c.5518-44C>A
intron
N/AENSP00000362933.2Q12955-5
ANK3
ENST00000355288.6
TSL:1
c.2938-44C>A
intron
N/AENSP00000347436.2Q12955-6

Frequencies

GnomAD3 genomes
AF:
0.762
AC:
109868
AN:
144186
Hom.:
40085
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.702
Gnomad AMI
AF:
0.761
Gnomad AMR
AF:
0.739
Gnomad ASJ
AF:
0.808
Gnomad EAS
AF:
0.839
Gnomad SAS
AF:
0.765
Gnomad FIN
AF:
0.737
Gnomad MID
AF:
0.771
Gnomad NFE
AF:
0.796
Gnomad OTH
AF:
0.777
GnomAD2 exomes
AF:
0.726
AC:
180923
AN:
249058
AF XY:
0.733
show subpopulations
Gnomad AFR exome
AF:
0.662
Gnomad AMR exome
AF:
0.566
Gnomad ASJ exome
AF:
0.787
Gnomad EAS exome
AF:
0.823
Gnomad FIN exome
AF:
0.693
Gnomad NFE exome
AF:
0.772
Gnomad OTH exome
AF:
0.725
GnomAD4 exome
AF:
0.758
AC:
1106365
AN:
1460506
Hom.:
421091
Cov.:
48
AF XY:
0.757
AC XY:
549935
AN XY:
726562
show subpopulations
African (AFR)
AF:
0.653
AC:
21802
AN:
33404
American (AMR)
AF:
0.574
AC:
25579
AN:
44548
Ashkenazi Jewish (ASJ)
AF:
0.788
AC:
20562
AN:
26080
East Asian (EAS)
AF:
0.785
AC:
31140
AN:
39664
South Asian (SAS)
AF:
0.714
AC:
61476
AN:
86080
European-Finnish (FIN)
AF:
0.687
AC:
36654
AN:
53340
Middle Eastern (MID)
AF:
0.747
AC:
4301
AN:
5760
European-Non Finnish (NFE)
AF:
0.773
AC:
859535
AN:
1111298
Other (OTH)
AF:
0.751
AC:
45316
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
12880
25760
38641
51521
64401
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20474
40948
61422
81896
102370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.762
AC:
109921
AN:
144284
Hom.:
40096
Cov.:
32
AF XY:
0.761
AC XY:
53667
AN XY:
70480
show subpopulations
African (AFR)
AF:
0.702
AC:
26962
AN:
38402
American (AMR)
AF:
0.738
AC:
10334
AN:
14000
Ashkenazi Jewish (ASJ)
AF:
0.808
AC:
2731
AN:
3382
East Asian (EAS)
AF:
0.839
AC:
4242
AN:
5058
South Asian (SAS)
AF:
0.766
AC:
3480
AN:
4546
European-Finnish (FIN)
AF:
0.737
AC:
7226
AN:
9804
Middle Eastern (MID)
AF:
0.761
AC:
216
AN:
284
European-Non Finnish (NFE)
AF:
0.796
AC:
52495
AN:
65914
Other (OTH)
AF:
0.777
AC:
1567
AN:
2016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1547
3094
4641
6188
7735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.720
Hom.:
12327
Bravo
AF:
0.717

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Intellectual disability-hypotonia-spasticity-sleep disorder syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
8.3
DANN
Benign
0.72
PhyloP100
0.70
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2393607; hg19: chr10-61802561; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.